Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention

Sponsor
Taipei City Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04388644
Collaborator
National Yang Ming University (Other)
300
3
3.3
100
30.4

Study Details

Study Description

Brief Summary

the retrospective observation study, the first line to care CAVID-19

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The satisfaction of using nature herbal medicine for frontline medical staffs to prevent COVID-19: a retrospective clinical study.

    The medical frontline staffs have the high risk to be infected during working. The stress and load were acuminated, especially when they got the similar symptoms as COVID-19. NHM has been used to early prevention for thousands of years9-12. It was well accept to take NHM for early prevention in many Asia-Pacific countries. Although many NHM remedies of COVID-19 treatment or prevention were reported, but the related study were lacking. To understand the pressure and the satisfaction of frontline medical staffs after taking JGF for early prevention we conducted this retrospective clinical study to explore the relationship in different groups.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan.
    Actual Study Start Date :
    Feb 20, 2020
    Anticipated Primary Completion Date :
    May 20, 2020
    Anticipated Study Completion Date :
    May 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. the number confirmed COVID-19 cases [8 weeks]

      The isolated person and first-line care person who taking JGF

    2. The person with COVID-19 like symptoms [8 weeks]

      The isolated person and first-line care person who taking JGF

    Secondary Outcome Measures

    1. The improving rate of COVID-19 like symptoms [8 weeks]

      The isolated person and first-line care person who taking JGF

    2. The satisfaction% to taking JGF [8 weeks]

      The isolated person and first-line care person who taking JGF

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The person first-line medical staff in hospital

    • the inspection personnel in airport

    • self-quarantine at home.

    • self-quarantine at office.

    Exclusion Criteria:
    • no willing to participate

    • allergy to herbal medicine

    • severe illness evaluated by physician

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Branch of Chinese Medicine, Taipei City Hospital Taipei Taiwan 886
    2 Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital Taipei Taiwan 886
    3 Taipei City Hospital Taipei Taiwan 886

    Sponsors and Collaborators

    • Taipei City Hospital
    • National Yang Ming University

    Investigators

    • Study Director: Chung-HUa Hsu, PhD, Taipei City Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Taipei City Hospital
    ClinicalTrials.gov Identifier:
    NCT04388644
    Other Study ID Numbers:
    • TCHIRB-10904015-E
    First Posted:
    May 14, 2020
    Last Update Posted:
    May 14, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Taipei City Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 14, 2020